Document is current
Any future updates will be listed below
-
Authors
Hachulla, Eric
Agard, Christian
Allanore, Yannick
Avouac, Jerome
Bader-Meunier, Brigitte
Belot, Alexandre
Berezne, Alice
Bouthors, Anne-Sophie
Condette-Wojtasik, Geraldine
Constans, Joël
De Groote, Pascal
Diot, Elisabeth
Dumas, Florence
Jego, Patrick
Joly, Francisca
Launay, David
Le Guern, Veronique
Le Quintrec, Janine-Sophie
Lescaille, Geraldine
Meune, Christophe
Moulin, Bruno
Nguyen, Christelle
Omeish, Nadine
Pene, Frederic
Richard, Marie-Aleth
Rochefort, Juliette
Roren, Alexandra
Sitbon, Olivier
Sobanski, Vincent
Truchetet, Marie-Elise
Mouthon, Luc
,
Bayen, Marc
Bergot, Emmanuel
Berthier, Sabine
Bosco, Julia
Bouhnik, Yoram
Chaigne, Benjamin
Cottin, Vincent
Crestani, Bruno
Deligny, Christophe
Descroix, Vianney
Farge, Dominique
Godard, Dominique
Granel, Brigitte
Guilpain, Philippe
Imbert, Bernard
Le Quellec, Alain
Lega, Christophe
Lok, Catherine
Maillard, Hélène
Martin, Thierry
Pugnet, Grégory
Queyrel, Viviane
Raffray, Loïc
Rilliard, Frédéric
Romier, Mélanie
Schuller, Laurence
Servettaz, Amélie
- License Information
-
More Information
Article History
Accepted: 26 April 2021
First Online: 26 July 2021
Declarations
:
: Not applicable.
: Not applicable.
: EH reports consulting fees/meeting fees from Actelion, Boehringer Ingelheim, Bayer, GSK, Roche-Chugai, Sanofi-Genzyme; speaking fees from Actelion, GSK, Roche-Chugai; and research funding from Octapharma, CSL Behring, GSK, Roche-Chugai and Actelion. CA reports no conflicts of interest. YA reports consulting fees/meeting fees from Actelion, Sanofi; Boehringer, Inventiva, Roche, Bayer, Sandoz, Medac, BMS; and research funding from Pfizer, BMS, Sandoz, Roche, Inventiva and Sanofi. JA reports no conflicts of interest. BBM reports no conflicts of interest. ABELOT reports no conflicts of interest. ABEREZNE reports no conflicts of interest. ASB reports no conflicts of interest. GW reports no conflicts of interest. JC reports no conflicts of interest. PDG reports consulting fees/meeting fees from Actelion, Bayer, MSD; speaking fees from Actelion, BAYER. ED reports consulting fees/meeting fees from Actelion. FD reports no conflicts of interest. PJ reports no conflicts of interest. FJ reports no conflicts of interest. DL reports no conflicts of interest. VL reports consulting fees/meeting fees from GSK and Astra-Zeneca. JSL reports no conflicts of interest. GL reports no conflicts of interest. CM reports no conflicts of interest. BM reports no conflicts of interest. CN reports no conflicts of interest. NO reports no conflicts of interest. FP reports no conflicts of interest. MAR reports no conflicts of interest. JR reports no conflicts of interest. AR reports no conflicts of interest. OS reports no conflicts of interest. VS reports no conflicts of interest. MET reports consulting fees/meeting fees from UCB, Lilly, Abbvie, MSD, Pfizer, Medac, Roche, Novartis, and BMS. LM reports no conflicts of interest.
